INSIGHTS ON CELL & GENE THERAPY LOGISTICS

• The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma

  As the industry faces increasing pressure to align with environmental, social, and governance (ESG) standards, companies must evaluate how to integrate supply chain management with these initiatives to drive sustainability and mitigate risks.

• Protecting The Foundation Of Biologics With Flexible, Scalable Cell Banking

  Safeguard your cell banks with secure, compliant storage and streamlined delivery solutions that keep manufacturing on schedule and therapies moving forward.

• ATMP Development In 2025: Promise, Pressure, And The Push To Scale

  Drive the next wave of cell and gene therapy innovation by overcoming operational, funding, and regulatory challenges to deliver life-changing treatments to patients faster.

• Built For Speed: How To Deliver Without Compromise

  Ensure fast, reliable, temperature-controlled logistics with a global infrastructure designed to protect critical biologic materials and keep development programs running smoothly and on schedule.

• Solving Fragmentation: Future-Proofing The Advanced Therapy Supply Chain

  Whether you are preparing for your first clinical shipment or scaling for global distribution, this conversation provides strategies to streamline operations, improve reliability, and deliver better patient outcomes.

• Purpose-Built Just For CGT

  Go inside a state-of-the-art cold chain facility that integrates advanced cryogenic storage, on-site specialty pharmacy, and streamlined distribution to eliminate friction across the supply chain.

• Challenges In Scaling Allogeneic Processes

  Learn practical strategies for optimizing harvest, cell separation, and large-volume freezing to ensure process efficiency, reduce risk, and maintain product viability.

• Leveraging Single-Use Solutions To Solve Working Cell Bank Challenges

  Discover how custom manifolds enhance allogeneic therapy development from formulation to commercialization by improving process control, scalability, and efficiency.

• Navigating Commercial Logistics: Key Considerations For Emerging CGT Manufacturers

  A successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.

• Interview: Trends With Single-Use Bottles In Bioprocessing

  Despite the rise of single-use bags, bottles continue to play a significant role in bioprocessing for the production of robust products. New closed-system technologies and sustainable materials could further boost their popularity.